Soligenix Inc (SNGX)

[bluejacket6]

Apparently someone here thinks earnings and cash flow are one and the same. LOL... How can you correlate earnings per share being negative, which until you have an approved product come to market, earnings will be negative and say big deal about cash flow "their losing money." Obviously, beating this point into the ground, earnings will be negative. This is biotech, cash flow is king, burn rates determine everything along with what stage certain drugs are in the pipeline. Fundamentally this stock is a home run even with a set back or two in the pipeline. SNGX is a cash cow from the grant perspective and there's no evidence the inflow of money will dry up. Top that with the late stage phase trials with more than adequate results. What does this equal??? UPSIDE :)))